Publications by authors named "Ashadur Zamal"
Article Synopsis
- Exogenous surfactant therapy is crucial for treating respiratory distress syndrome (RDS) in preterm infants, and the study focuses on the effectiveness of less invasive surfactant administration (LISA) using two types: beractant and poractant alfa.
- In a randomized controlled trial, 120 preterm infants (28-33 weeks) with RDS were treated with either beractant (100 mg/kg) or poractant-alfa (200 mg/kg), with intubation needs within 72 hours as the primary outcome.
- Results showed both treatments required intubation in 3.3% of cases, with no significant differences in effectiveness, but beractant was more cost-effective than poractant
